Melissa Joy Call

13PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringPharmacogenomicsGenomics and transcriptomicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 29, 2026
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

|May 12, 2026
The transmembrane domain structure of TNFR1 suppresses ligand-independent autoactivation but is not required for TNF-induced signaling.

|Sep 05, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity.

Xinyu Wu, Shane M Devine, Margareta Go

|Sep 04, 2025
Insights from deep mutational scanning in the context of an emerging pathogen.

Melissa J Call, Matthew E Call, Xinyu Wu

|Apr 03, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

Stefanie M Bader, Dale J Calleja, Shane M Devine

|Jul 23, 2024
Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape.

Xinyu Wu, Margareta Go, Julie V Nguyen

Pageof 3

Frequent Collaborators

9 joint publications

Matthew Edwin Call

3 joint publications

Xinyu Wu

2 joint publications

Margareta Go

2 joint publications

Guillaume Lessene